MINELLI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 6.182
AS - Asia 3.634
EU - Europa 2.835
SA - Sud America 809
AF - Africa 101
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 13.586
Nazione #
US - Stati Uniti d'America 5.995
CN - Cina 1.161
SG - Singapore 1.160
BR - Brasile 683
IT - Italia 599
PL - Polonia 481
UA - Ucraina 420
HK - Hong Kong 399
DE - Germania 326
VN - Vietnam 305
FR - Francia 226
FI - Finlandia 213
BD - Bangladesh 191
GB - Regno Unito 168
TR - Turchia 113
IN - India 99
RU - Federazione Russa 97
CA - Canada 95
IE - Irlanda 95
MX - Messico 51
AR - Argentina 47
ZA - Sudafrica 36
ID - Indonesia 33
IQ - Iraq 32
AT - Austria 28
EC - Ecuador 27
NL - Olanda 27
SE - Svezia 26
PK - Pakistan 23
ES - Italia 22
CZ - Repubblica Ceca 21
SA - Arabia Saudita 20
JP - Giappone 18
MA - Marocco 18
LT - Lituania 17
AU - Australia 16
BE - Belgio 16
VE - Venezuela 16
KE - Kenya 11
NO - Norvegia 11
CL - Cile 10
CO - Colombia 10
CR - Costa Rica 8
JO - Giordania 8
KZ - Kazakistan 8
NG - Nigeria 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
DZ - Algeria 7
EG - Egitto 7
HN - Honduras 7
TT - Trinidad e Tobago 7
UZ - Uzbekistan 7
IL - Israele 6
JM - Giamaica 6
PE - Perù 6
AL - Albania 5
KR - Corea 5
PY - Paraguay 5
CH - Svizzera 4
EU - Europa 4
HU - Ungheria 4
KG - Kirghizistan 4
LV - Lettonia 4
OM - Oman 4
TN - Tunisia 4
AM - Armenia 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IR - Iran 3
LK - Sri Lanka 3
MY - Malesia 3
PA - Panama 3
RO - Romania 3
SV - El Salvador 3
UY - Uruguay 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
ET - Etiopia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
Totale 13.571
Città #
Fairfield 616
Singapore 609
Ashburn 541
Woodbridge 527
Warsaw 475
Hong Kong 397
Jacksonville 300
Houston 281
Ann Arbor 265
San Jose 265
Seattle 253
Cambridge 230
The Dalles 220
Beijing 217
Wilmington 194
New York 190
Princeton 167
Chandler 150
Los Angeles 136
Helsinki 115
Lauterbourg 115
Dearborn 112
Brescia 111
Ho Chi Minh City 103
Nanjing 100
Dublin 90
Istanbul 90
Munich 87
São Paulo 70
Milan 69
Buffalo 63
Hanoi 53
Des Moines 52
San Francisco 49
Chicago 48
Turku 47
Nanchang 45
Redondo Beach 45
Jinan 44
Shanghai 44
Shenyang 44
Bolzano 40
Hebei 39
Moscow 39
Toronto 39
Verona 38
Changsha 37
Council Bluffs 37
Santa Clara 35
Boardman 34
Dong Ket 34
Dallas 32
San Diego 32
Orem 31
Lancaster 26
Tianjin 26
Frankfurt am Main 24
London 24
Rome 24
Brooklyn 23
Johannesburg 22
Nuremberg 22
Atlanta 19
Guangzhou 19
Mexico City 19
Montreal 19
Rio de Janeiro 19
Zhengzhou 19
Belo Horizonte 18
Denver 17
Ningbo 17
Brussels 16
Haiphong 16
Salt Lake City 16
Tokyo 16
Brno 15
Hangzhou 15
Norwalk 15
Stockholm 15
Da Nang 13
Jakarta 13
Jiaxing 13
Sorocaba 13
Chennai 12
Haikou 12
Lanzhou 12
Brasília 11
Curitiba 11
Düsseldorf 11
Guayaquil 11
Hefei 11
Poplar 11
Taizhou 11
Naples 10
Phoenix 10
Quito 10
Ankara 9
Fuzhou 9
Lappeenranta 9
Orange 9
Totale 8.808
Nome #
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 320
New Copy Number Variations in Schizophrenia 318
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 264
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 228
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) 207
Clinical efficacy of trauma-focused psychotherapies in treatment-resistant depression (TRD) in-patients: A randomized, controlled pilot-study 199
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 194
The role of the potassium channel gene KCNK2 in major depressive disorder 193
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder 187
Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder 180
The role of GRIK4 gene in treatment-resistant depression 179
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 178
The Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders 170
Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. 168
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 165
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 164
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study 163
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. 159
MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder 159
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia 154
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 154
On the neural control of social emotional behavior 153
An association of GRIK3 Ser310Ala functional polymorphism with personality traits. 152
Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients 147
The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits. 146
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. 145
Erbb3 leukocytes mRNA levels as biomarker of Major Depression. 145
PCLO gene: Its role in vulnerability to major depressive disorder. 144
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 144
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 143
Effectiveness of cognitive behavioral therapy in the treatment of fibromyalgia syndrome: a meta-analytic literature review 138
Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients 138
Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression 137
Seizure Adequacy Markers and the Prediction of Electroconvulsive Therapy Response 136
Influence of GRIK4 genetic variants on the electroconvulsive therapy response 136
5-Httlpr/Rs25531 And Fkbp5 Polymorphisms Epistasis In Treatment-Resistant Depressed Patients 135
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients 133
Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles 130
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients. 128
Establishment and characterization of induced pluripotent stem cell (iPSCs) line UNIBSi014-A from a healthy female donor 128
Serotonin transporter gene polymorphisms and treatment-resistant depression. 126
Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients 126
Long-lasting effects of high frequency repetitive transcranial magnetic stimulation in major depressed patients 126
International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic) 126
Costituenti cognitive di invidia, vergogna e senso di colpa associate alla gravità della psicopatologia 125
Lateralized readiness potential elicited by undetected visual stimuli 125
The Elephant in the Room: A Cross-Sectional Study on the Stressful Psychological Effects of the COVID-19 Pandemic in Mental Healthcare Workers 125
The factor structure analysis for the positive and negative syndrome scale (PANSS) in pharmacogenetics and pharmacogenomics studies. 124
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response 124
New Copy Number Variations in Schizophrenia Italian Patients 123
Analysis of Citalopram response heterogeneity among STAR*D patients using in-silico methods 119
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response 119
Childhood neglect, the neglected trauma. A systematic review and meta-analysis of its prevalence in psychiatric disorders 118
Childhood trauma and glucose metabolism in patients with first-episode psychosis 118
Is blindsight in normals akin to blindsight following brain damage? 117
Social Cognition in a Research Domain Criteria Perspective: A Bridge Between Schizophrenia and Autism Spectra Disorders 116
Study of the genetic architecture behind mood disorders by whole exome sequencing on a large Italian pedigree 114
[Effectiveness of cognitive-associated with behavioral therapy psychopharmacological depression. Literature review meta-analyses] 113
Psychological impact of Covid-19 pandemic in mental healthcare workers: a cross-sectional study in an Italian Department of Mental Health 110
Vascular endothelial growth factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in depressed patients. 110
Biological correlates of early life stressful events in major depressive disorder 110
Genome-Wide pharmacogenomics analysis of early antipsychotic (risperidone) response in patients with schizophrenia 109
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 108
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 106
Blues in the brain and beyond: Molecular bases of major depressive disorder and relative pharmacological and non-pharmacological treatments 106
Investigating an in silico approach for prioritizing antidepressant drug prescription based on drug-induced expression profiles and predicted gene expression 103
Meta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality Consortium 102
Treatments of trauma: A review of actions and techniques 101
P.0106 Pharmacogenetic gene variants in treatment-resistant depression: preliminary results of a pilot study 98
Blood transcriptomic analysis reveals a distinct molecular subtype of treatment resistant depression compared to non-treatment resistant depression 96
Assessment of haptoglobin alleles in autism spectrum disorders 95
Biological markers of sex-based differences in major depressive disorder and in antidepressant response 94
Molecular biomarkers of electroconvulsive therapy effects and clinical response: Understanding the present to shape the future 94
The role of pharmacogenetics in the treatment of major depressive disorder: a critical review 91
Genetics of anxiety disorders. 90
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 90
P.264 Association of single nucleotide polymorphisms in the 3’ untranslated region of SLC1A2 with major depressive disorder and relative endophenotypes 88
Peripheral BDNF levels and personality traits in a sample of subjects non affected by psychiatric diseases 85
Vascular Endothelial Growth Factor (VEGF) serum concentration: putative predictive biomarker for Electroconvulsive Therapy in depressed patients. 84
Leukocyte Telomere Length and Mitochondrial DNA Copy Number in Treatment-Resistant Depression and Response to Electroconvulsive Therapy: A Pilot Longitudinal Study 83
Personality traits in an Italian sample: Relationship with anxiety and depression 82
DNA methylation changes in association with trauma-focused psychotherapy efficacy in treatment-resistant depression patients: a prospective longitudinal study 82
No Less No More: The number of electroconvulsive therapy (ECT) trials for symptomatology improvement. 82
Telomere length and mitochondrial DNA copy number in association with trauma-focused psychotherapy efficacy 81
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response 79
Mitochondrial DNA copy number is significantly increased in bipolar disorder patients and is correlated with long-term lithium treatment 78
Investigating the role of leukocyte telomere length in treatment-resistant depression and in response to electroconvulsive therapy 78
The role of MED22 and its transcriptional interactions with childhood trauma and trauma-focused psychotherapy in patients with major depressive disorder 77
Transcriptional Modulation of Stress-Related Genes in Association with Early Life Stress Exposure and Trauma-Focused Psychotherapy in Treatment-Resistant Depression Patients 77
Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients 77
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients 76
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 76
A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe 76
Fibroblasts Transcriptional Profiles In Schizophrenia 76
Everything changes but nothing changes: gender stereotypes in the Italian population 73
THE FACTOR STRUCTURE FOR THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) IN PHARMACOGENETICS: 102T/C 5-HT2A POLYMORPHISM AND RESPONSE TO RISPERIDONE 72
ELECTROPHYSIOLOGICAL EVIDENCE OF MOTOR PREPARATION IN RESPONSE TO UNDETECTED VISUAL STIMULI. 72
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review 68
A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 e CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder 65
Association of pharmacodynamic genes with treatment outcomes in major depressive disorder: results from a Sardinian cohort 64
Totale 12.609
Categoria #
all - tutte 62.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202180 0 0 0 0 0 0 0 0 0 0 0 80
2021/2022758 51 99 29 11 11 40 78 46 90 74 48 181
2022/2023566 104 5 16 35 31 158 4 61 84 10 40 18
2023/2024807 45 19 77 71 37 140 24 21 169 19 35 150
2024/20252.114 32 27 28 253 142 178 179 84 198 303 370 320
2025/20264.769 415 597 312 623 520 297 648 192 301 396 280 188
Totale 13.807